SHREE GANESH BIO-TECH (INDIA) LTD.
Market Cap.(`)
|
48.23 Cr.
|
P/BV
|
0.81
|
Book Value (`)
|
1.49
|
52 Week High/Low ( ` )
|
2/1
|
FV/ML
|
1/1
|
P/E(X)
|
23.68
|
Book Closure
|
28/09/2023
|
EPS (`)
|
0.05
|
Div Yield (%)
|
0.00
|
You can view the Standalone
Ratio Analysis
for the last 5 years.
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | 0.05 | 0.13 | 0.16 | 0.12 | 0.90 |
Diluted EPS (Rs.) | 0.05 | 0.13 | 0.16 | 0.12 | 0.90 |
Cash EPS (Rs.) | 0.05 | 0.12 | 0.15 | 0.11 | 0.89 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 1.56 | 3.03 | 29.00 | 28.84 | 28.72 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 1.56 | 3.03 | 29.00 | 28.84 | 28.72 |
Revenue From Operations / Share (Rs.) | 1.57 | 3.64 | 8.64 | 1.24 | 2.94 |
PBDIT / Share (Rs.) | 0.06 | 0.17 | 0.35 | 0.11 | 0.89 |
PBIT / Share (Rs.) | 0.06 | 0.17 | 0.35 | 0.11 | 0.89 |
PBT / Share (Rs.) | 0.06 | 0.17 | 0.21 | 0.11 | 0.89 |
Net Profit / Share (Rs.) | 0.05 | 0.12 | 0.15 | 0.11 | 0.89 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 4.34 | 4.81 | 4.11 | 9.60 | 30.53 |
PBIT Margin (%) | 4.34 | 4.81 | 4.11 | 9.55 | 30.51 |
PBT Margin (%) | 4.34 | 4.81 | 2.48 | 9.53 | 30.50 |
Net Profit Margin (%) | 3.26 | 3.47 | 1.84 | 9.53 | 30.50 |
Return on Networth / Equity (%) | 3.26 | 4.18 | 0.54 | 0.41 | 3.12 |
Return on Capital Employeed (%) | 4.35 | 5.80 | 1.22 | 0.40 | 3.11 |
Return On Assets (%) | 2.56 | 2.69 | 0.42 | 0.36 | 2.79 |
Asset Turnover Ratio (%) | 0.72 | 0.86 | 0.24 | 0.03 | 0.12 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 1.16 | 1.32 | 1.71 | 2.96 | 2.89 |
Quick Ratio (X) | 1.16 | 1.32 | 1.71 | 2.96 | 2.89 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 27148.00 | 25698.52 | 1772.11 | 446.33 | 2252.96 |
Interest Coverage Ratio (Post Tax) (%) | 20388.00 | 18546.65 | 1492.04 | 444.33 | 2251.62 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 40.18 | 185.32 | 236.35 | 259.68 | 239.33 |
EV / Net Operating Revenue (X) | 0.64 | 2.55 | 13.73 | 105.00 | 40.78 |
EV / EBITDA (X) | 14.80 | 52.95 | 333.77 | 1093.61 | 133.57 |
MarketCap / Net Operating Revenue (X) | 0.65 | 2.55 | 13.72 | 104.93 | 40.76 |
Price / BV (X) | 0.65 | 3.07 | 4.09 | 4.52 | 4.18 |
Price / Net Operating Revenue (X) | 0.65 | 2.55 | 13.72 | 105.00 | 40.76 |
EarningsYield | 0.05 | 0.01 | 0.00 | 0.00 | 0.01 |